Managing Director Mr. Alok Kumar – Hon’ble delegation member of CII delegation to Minsk Belarus 24th Sept 2018, announced upcoming investment and business with Belarus.
Onco plant at Goa -internal and external infra works are in full swing target to operational by 4th quarter of 2018
Managing Director Mr. Alok Kumar - Invitee guest during opening of Belarus Consulate at Mumbai
Plant 1 OSD , 4 Dept, Atgaon, Thane ,India - Russian GMP, Belarus GMP and PIC/s Certified.
3 new products are schedule to launch for Anti fungal, Laxative and Respiratory
7-Mar-2019 10:00 AM: Opening Ceremony of Novalok LLC (Oral Solid Dose Plant) at Belarus, 31761, Grodno District, SKidel, st. Kizevich 50
Competition makes things come out right. Well, what does that mean in health care? More hospitals so they compete with each other. More doctors compete with each other. More pharmaceutical companies. We set up war. Wait a minute, let's talk about the patient. The patient doesn't need a war.
Today Lok-Beta is a key player in the Indian market, with a wide range of products in various segments such as Anti-Inflammatory, Antibiotics, Anti-Histaminics, Antitussive and planning to enter in new segment Neutraceuticals, Antimalarial, Antihypertensive and Anti-Diabetic, Gastroenterology.
Lok-Beta enjoys a strong rapport with the medical profession including specialist, who have accepted Lok-Beta's product for their High quality, efficacy and affordability.
Lok-Beta has a strong presence with its own team in the states of UP, Jharkhand, Bihar and Maharashtra aiming to penetrate PAN India market.
The majority of products marketed are for the treatment and/or prevention of chronic and recurrent illness. Lok-Beta concentrates on the following therapeutic area with niche molecules.